Vivos (RDGL) FCF Margin Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Vivos | - | - | -3,105.00 | 215,417.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 215,417.00 |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | -240,036.00 |
| Mar 31, 2025 | 125,434.00 |
| Sep 30, 2024 | -892,894.00 |
| Sep 30, 2023 | -54,289.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | -204,140.00 |
| Sep 30, 2019 | -7.96 Mn |
| Mar 31, 2018 | 190,911.00 |
| Mar 31, 2017 | -382,541.00 |
| Sep 30, 2016 | 7.76 Mn |
| Mar 31, 2016 | -1.19 Mn |
| Sep 30, 2015 | -9,429.00 |
| Mar 31, 2015 | -176,829.00 |
| Jun 30, 2014 | -281,629.00 |
| Mar 31, 2014 | -280,987.00 |